HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia
Mei Guo(Academy of Military Medical Sciences), Bo Cai(Academy of Military Medical Sciences), Nelson J. Chao(Duke Medical Center), Linhua Yang(Shanxi University), Xin-Rong Zhan(Xinxiang Central Hospital), Xuliang Shen(Changzhi Medical College), Hui‐Sheng Ai(Academy of Military Medical Sciences), Jun-Xiao Qiao(Second Artillery General Hospital of Chinese People's Liberation Army), Tie-Qiang Liu(Academy of Military Medical Sciences), David A. Rizzieri(Duke University), Anthony D. Sung(Cornell University), Elizabeth F. Krakow(Fred Hutch Cancer Center), Rafael F. Duarte(Institut Català d'Oncologia), Hongxia Zhao(Second Affiliated Hospital of Zhejiang University), Bo Yao(Qingdao University), Rafael Forés(Comunidad de Madrid), Juan Wang(Shanghai Jiao Tong University), Li Liu(Air Force Medical University), Min Zhou(Nanjing Drum Tower Hospital), Jian‐Hui Qiao(Second Artillery General Hospital of Chinese People's Liberation Army), Zheng Dong(University of Chinese Academy of Sciences), Depei Wu(Soochow University), Wei Wei Liu(Academy of Military Medical Sciences), Jianyong Li(Jiangsu Province Hospital), Zhiqing Liu, Hong‐Li Zuo(Academy of Military Medical Sciences), Wan-Jun Sun(Second Artillery General Hospital of Chinese People's Liberation Army), Chang‐Lin Yu(Academy of Military Medical Sciences), Yajing Huang(Tongji Hospital), Sixuan Qian(Jiangsu Province Hospital), Qi‐Yun Sun(Academy of Military Medical Sciences), Yangyi Bao(Hefei First People's Hospital), Kai‐Xun Hu(Academy of Military Medical Sciences), Ann Mohrbacher(University of Southern California)
Cited by 48
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2020|739